CYCLOPHOSPHAMIDE VS MELPHALAN IN TREATMENT OF PLASMA CELL MYELOMA

[1] BERGSAGEL DE, 1962, CANCER CHEMOTH REP, V21, P87

[2] BROCK N, 1967, CANCER, V20, P900, DOI 10.1002/1097-0142(1967)20:5<900::AID-CNCR2820200552>3.0.CO

[3] 2-Y

[4] PLASMACYTIC MYELOMA - A STUDY OF RELATIONSHIP OF SURVIVAL TO VARIOUS CLINICAL MANIFESTATIONS AND ANOMALOUS PROTEIN TYPE IN 112 PATIENTS [J]. AMERICAN JOURNAL OF MEDICINE, 1967, 42 (06) : 937 - +

[5] Karnofsky DA, 1949, EVALUATION CHEMOTHER, P191

[6] KORST DR, 1964, JAMA-J AM MED ASSOC, V189, P758

[7] MacLeod CM, 1949, EVALUATION CHEMOT ED, P191

[8] CLASSIFICATION OF MYELOMA PROTEINS, BENCE JONES PROTEINS, AND MACROGLOBULINS INTO 2 GROUPS ON BASIS OF COMMON ANTIGENIC CHARACTERS [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1962, 116 (06) : 859 - &

[9] MELPHALAN (L-PHENYLALANINE NITROGEN MUSTARD) TREATMENT IN MYELOMATOSIS - REPORT OF 46 CASES [J]. ACTA RADIOLOGICA-THERAPY PHYSICS BIOLOGY, 1966, 4 (01): : 33 - &

[10] OSGOOD EE, 1960, CANCER CHEMOTH REP, V9, P1

[1] BERGSAGEL DE, 1962, CANCER CHEMOTH REP, V21, P87

[2] BROCK N, 1967, CANCER, V20, P900, DOI 10.1002/1097-0142(1967)20:5<900::AID-CNCR2820200552>3.0.CO

[3] 2-Y

[4] PLASMACYTIC MYELOMA - A STUDY OF RELATIONSHIP OF SURVIVAL TO VARIOUS CLINICAL MANIFESTATIONS AND ANOMALOUS PROTEIN TYPE IN 112 PATIENTS [J]. AMERICAN JOURNAL OF MEDICINE, 1967, 42 (06) : 937 - +

[5] Karnofsky DA, 1949, EVALUATION CHEMOTHER, P191

[6] KORST DR, 1964, JAMA-J AM MED ASSOC, V189, P758

[7] MacLeod CM, 1949, EVALUATION CHEMOT ED, P191

[8] CLASSIFICATION OF MYELOMA PROTEINS, BENCE JONES PROTEINS, AND MACROGLOBULINS INTO 2 GROUPS ON BASIS OF COMMON ANTIGENIC CHARACTERS [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1962, 116 (06) : 859 - &

[9] MELPHALAN (L-PHENYLALANINE NITROGEN MUSTARD) TREATMENT IN MYELOMATOSIS - REPORT OF 46 CASES [J]. ACTA RADIOLOGICA-THERAPY PHYSICS BIOLOGY, 1966, 4 (01): : 33 - &

[10] OSGOOD EE, 1960, CANCER CHEMOTH REP, V9, P1